TUBERCULOSIS by NGC-AHRQ / WHO

HOY en http://elbiruniblogspotcom.blogspot.com
TODO TUBERCULOSIS
World Health Organization

1. Case-finding strategies. In: Guidelines for the programmatic management of drug-resistant tuberculosis.

2. Category IV recording and reporting system. In: Guidelines for the programmatic management of drug-resistant tuberculosis.

3. DR-TB and HIV infection. In: Guidelines for the programmatic management of drug-resistant tuberculosis.

4. Drug resistance and infection control. In: Guidelines for the programmatic management of drug-resistant tuberculosis.

5. Initial evaluation, monitoring of treatment and management of adverse effects. In: Guidelines for the programmatic management of drug-resistant tuberculosis.

6. Laboratory aspects. In: Guidelines for the programmatic management of drug-resistant tuberculosis.

7.Management of contacts of MDR-TB patients. In: Guidelines for the programmatic management of drug-resistant tuberculosis.

8. Management of patients after MDR-TB treatment failure. In: Guidelines for the programmatic management of drug-resistant tuberculosis.

9. Management of second-line antituberculosis drugs. In: Guidelines for the programmatic management of drug-resistant tuberculosis.

10. Managing DR-TB through patient-centred care. In: Guidelines for the programmatic management of drug-resistant tuberculosis.

11. Mono-resistant and poly-resistant strains. In: Guidelines for the programmatic management of drug-resistant tuberculosis.

12. Treatment delivery and community-based DR-TB support. In: Guidelines for the programmatic management of drug-resistant tuberculosis.

13. Treatment of DR-TB in special conditions and situations. In: Guidelines for the programmatic management of drug-resistant tuberculosis.

14. Treatment strategies for MDR-TB and XDR-TB. In: Guidelines for the programmatic management of drug-resistant tuberculosis.